scienceliberal
Inclusive Data for Rare Diseases: Why It Matters
Monday, May 4, 2026
Rare diseases touch only a few people, often in far‑off places. Researchers gather data from many sites to study these conditions, but the way they collect personal details can leave out key groups.
What Was Studied?
The study examined how frequently researchers ask about:
- Geographic location
- Race or culture
- Job type
- Gender
- Religion
- Educational level
- Financial situation
- Social ties
It also checked whether extra details such as age or disabilities are included.
Findings
Using the PROGRESS‑Plus guide, the review revealed that many studies omit these critical pieces of information. When data are missing:
- It becomes hard to determine if research truly represents everyone affected by a rare disease.
- Potential disparities in disease manifestation and spread across communities remain hidden.
Why It Matters
Complete demographic data enables scientists to:
- Spot differences in how diseases appear and spread.
- Design fair treatment plans, ensuring no group is overlooked when new therapies are tested.
Call to Action
The paper urges researchers to adopt a standard set of questions covering all PROGRESS‑Plus items. Doing so would make rare disease studies:
- More trustworthy
- More useful for doctors, patients, and policy makers alike
Actions
flag content